EUVIMEDEUVIMED entdecken
Open Access

Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis

Anna L Wilt iD, David B Meya iD, Fiona V Cresswell iD, Abduljewad Wele, Mable Kabahubya iD, Enock Kagimu iD, Jane Gakuru iD, Timothy Mugabi iD, Sarah Kimuda iD, Suzan Namombwe iD, Asmus Tukundane iD, Elizabeth C Okafor iD und 7 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Anna L Wilt und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, HIV Infections, Inflammation, Cerebrospinal Fluid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIAID NIH HHS, National Institutes of Neurologic Diseases and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Outcomes in tuberculous meningitis (TBM) are closely linked to host inflammation. Anti-inflammatory corticosteroid therapy improves survival in HIV-negative TBM, but not in people with HIV, among whom TBM is fatal in 40–50% of cases. Therefore, we investigated how mortality is associated with the local immune response in people with HIV-associated TBM.

Methods

We measured baseline concentrations of immune signaling mediators in cerebrospinal fluid (CSF) of 149 adults with HIV in Uganda, who presented with definite or probable TBM. Participants received both antimycobacterial and corticosteroid therapy.

Results

At baseline, non-survivors had more severe TBM disease and lower blood CD4 T cells than survivors. Mortality at 90 days was strongly associated with CSF hypo-inflammation. Cerebrospinal fluid interferon gamma (IFN-γ) was most differentially expressed by survivors (2.2 log2-fold change higher, P = .003), and 90-day mortality was lower with increasing concentrations (tertile-1 = 50%, tertile-2 = 41%, tertile-3 = 18%; P = .006). Even among people who successfully mounted a CSF cellular immune response (>5 white cells/µL CSF), those with low CSF IFN-γ had higher risk of death (hazard ratio = 3.10 [1.44–6.68]). Interleukin-13 had a more complex relationship, with lower mortality among people with intermediate CSF interleukin-13 concentrations but higher at the 2 extremes (tertile-1 = 45%, tertile-2 = 22%, tertile-3 = 40%; P = .017). Of all subgroups, those with both peripheral CD4 depletion and low CSF IFN-γ had the highest mortality (63%).

Conclusions

In adults with HIV-associated TBM receiving dexamethasone, mortality was strongly associated with CSF hypo-inflammation. Although steroids may be appropriate in those with high inflammation, personalized approaches to immunotherapy are likely necessary to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, MeningealHIV InfectionsInflammationCerebrospinal FluidHumansFemaleAdultMaleUgandaInterferon-gammaAntitubercular AgentsMiddle AgedCytokinesCD4 Lymphocyte Count

Stichwörter der Autor:innen

HIVcerebrospinal fluidcytokinestuberculosistuberculous meningitis

Substanzen

Interferon-gammaAntitubercular AgentsCytokines

Autor:innen und Institutionen

  • Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Global Health and Infection, Brighton and Sussex Medical School, Brighton, United Kingdom.
  • Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Anna L Wilt, David B Meya, Fiona V Cresswell, Mable Kabahubya, Enock Kagimu, Jane Gakuru, Timothy Mugabi, Sarah Kimuda, Suzan Namombwe, Asmus Tukundane, Elizabeth C Okafor, Samuel Okurut, James E Scriven, Biyue Dai, Nicole Engen, Nathan C Bahr, David R Boulware, Tyler D Bold

Förderung

  • NINDS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Neurologic Diseases and Stroke
  • FIC NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIH HHS
  • Fogarty International Center
  • National Institutes of Health

Zitieren

APA

Wilt, A. L., Meya, D. B., Cresswell, F. V., Wele, A., Kabahubya, M., Kagimu, E., Gakuru, J., Mugabi, T., Kimuda, S., Namombwe, S., Tukundane, A., Okafor, E. C., Okurut, S., Scriven, J. E., Dai, B., Engen, N., Bahr, N. C., Boulware, D. R., & Bold, T. D. (2026). Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag032

Vancouver

Wilt AL, Meya DB, Cresswell FV, Wele A, Kabahubya M, Kagimu E, et al. Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag032

BibTeX
@article{Wilt2026,
  author = {Wilt, Anna L and Meya, David B and Cresswell, Fiona V and Wele, Abduljewad and Kabahubya, Mable and Kagimu, Enock and Gakuru, Jane and Mugabi, Timothy and Kimuda, Sarah and Namombwe, Suzan and Tukundane, Asmus and Okafor, Elizabeth C and Okurut, Samuel and Scriven, James E and Dai, Biyue and Engen, Nicole and Bahr, Nathan C and Boulware, David R and Bold, Tyler D},
  title = {Cerebrospinal Fluid Hypo-inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag032}
}
Kostenlos starten →